BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 23651911)

  • 21. Should we operate on microscopic N2 non-small cell lung cancer?
    Fontaine E; McShane J; Carr M; Shackcloth M; Mediratta N; Page R; Poullis M
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):956-61; discussion 961. PubMed ID: 21330443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
    Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
    Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer.
    Greillier L; Thomas P; Loundou A; Doddoli C; Badier M; Auquier P; Barlési F
    Clin Lung Cancer; 2007 Nov; 8(9):554-61. PubMed ID: 18186960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
    Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
    Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients.
    Pompili C; Brunelli A; Xiumé F; Refai M; Salati M; Socci L; Di Nunzio L; Sabbatini A
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):99-105. PubMed ID: 21159520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.
    Voltolini L; Bongiolatti S; Luzzi L; Bargagli E; Fossi A; Ghiribelli C; Rottoli P; Gotti G
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e17-23. PubMed ID: 23129356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
    Gao YS; Xing XZ; Shao K; Feng XL; He J
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of superior vena cava resection for lung cancer. Analysis of prognostic factors.
    Spaggiari L; Magdeleinat P; Kondo H; Thomas P; Leon ME; Rollet G; Regnard JF; Tsuchiya R; Pastorino U
    Lung Cancer; 2004 Jun; 44(3):339-46. PubMed ID: 15140547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
    Manser RL; Wright G; Byrnes G; Hart D; Conron M; Carter R; McLachlan SA; Campbell DA
    Lung Cancer; 2006 Aug; 53(2):217-29. PubMed ID: 16765475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Segmental resection spares pulmonary function in patients with stage I lung cancer.
    Keenan RJ; Landreneau RJ; Maley RH; Singh D; Macherey R; Bartley S; Santucci T
    Ann Thorac Surg; 2004 Jul; 78(1):228-33; discussion 228-33. PubMed ID: 15223434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis and outcomes of sleeve resection versus pneumonectomy.
    Parissis H; Leotsinidis M; Hughes A; McGovern E; Luke D; Young V
    Asian Cardiovasc Thorac Ann; 2009 Apr; 17(2):175-82. PubMed ID: 19592550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical risk model for the evaluation of bronchopleural fistula in non-small cell lung cancer after pneumonectomy.
    Hu XF; Duan L; Jiang GN; Wang H; Liu HC; Chen C
    Ann Thorac Surg; 2013 Aug; 96(2):419-24. PubMed ID: 23782644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
    Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
    Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.